MONTREAL, Aug. 25, 2023 (GLOBE NEWSWIRE) — Terranueva Corporation (CSE:TEQ) (“Terranueva” or the “Company”) is pleased to report revenue of $636,299 and $963,502, respectively, for the three and nine month periods ended to be announced June 30, 2023. The Company’s MD&A and Unaudited Consolidated Financial Statements for the third quarter ended June 30, 2023 are available on SEDAR.

Terranueva is also pleased to announce that it has entered into an agreement with Canna-Culture Inc., a leader in the production of high-quality cannabis in Quebec, to implement a reliable supply strategy for our cannabis flower raw material commensurate with our growing demand Main customers, of the SQDC, react.

Each company is committed to working in a spirit of partnership with the other in order to optimize the supply of quality products and the marketing of a greater number of cannabis products with genetics appreciated by Quebec customers and to share their best practices in this area.

Following this announcement, the management of Terranueva confirms that the process announced on January 10th and March 15th, 2023 to ensure the continuity of the activities and operations of the company is proceeding according to the steps and deadlines established itself, with the support of its main creditors .

ABOUT TERRANUEVA

Terranueva Pharma Corporation, its wholly owned subsidiary, holds the necessary licenses from Health Canada to carry out its mission.

To learn more about Terranueva, visit www.terranueva.ca.

Neither the CSE nor its Regulation Service Provider (as that term is defined in the CSE Policies) accepts responsibility for the adequacy or accuracy of this press release.

For more information, please contact:

Peter Polatos, Acting President

Phone: (450) 591-1011